{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:58:48Z","timestamp":1769155128159,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jmii.2024.03.001","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T21:42:18Z","timestamp":1709934138000},"page":"403-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies"],"prefix":"10.1016","volume":"57","author":[{"given":"Tzong-Yow","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Ting","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Hsiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szu-Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Fu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Hsien","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Jui","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6058-6224","authenticated-orcid":false,"given":"Wang-Da","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6877-5345","authenticated-orcid":false,"given":"Kuan-Yin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Shan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristine","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pao-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0074-7721","authenticated-orcid":false,"given":"Hsin-Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3098-6371","authenticated-orcid":false,"given":"Huai-Hsuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai-Chung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-Ju","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jann-Tay","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang-Huei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Ching","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1816-9010","authenticated-orcid":false,"given":"Yee-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2024.03.001_bib1","series-title":"WHO coronavirus (COVID-19) dashboard","year":"2023"},{"key":"10.1016\/j.jmii.2024.03.001_bib2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmii.2024.03.001_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100775","article-title":"When hematologic malignancies meet COVID-19 in the United States: infections, death and disparities","volume":"47","author":"Wang","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.jmii.2024.03.001_bib4","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s15010-022-01869-w","article-title":"Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study","volume":"50","author":"Oliva","year":"2022","journal-title":"Infection"},{"key":"10.1016\/j.jmii.2024.03.001_bib5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13045-021-01177-0","article-title":"COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)","volume":"14","author":"Pagano","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jmii.2024.03.001_bib6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/jamaoncol.2022.6815","article-title":"Association of COVID-19 vaccination with breakthrough infections and complications in patients with cancer","volume":"9","author":"Gong","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jmii.2024.03.001_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1125030","article-title":"Outcome of COVID-19 in allogeneic stem cell transplant recipients: results from the EPICOVIDEHA registry","volume":"14","author":"Busca","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jmii.2024.03.001_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.100931","article-title":"COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: a clarion call for maintaining mitigation and ramping-up research","volume":"54","author":"Wang","year":"2022","journal-title":"Blood Rev"},{"key":"10.1016\/j.jmii.2024.03.001_bib9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(22)00056-3","article-title":"Omicron severity: milder but not mild","volume":"399","author":"Nealon","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2024.03.001_bib10","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood.2022017257","article-title":"Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey","volume":"140","author":"Pagano","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jmii.2024.03.001_bib11","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/ajh.26209","article-title":"Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy","volume":"96","author":"Dulery","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jmii.2024.03.001_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101939","article-title":"Nirmatrelvir\/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry","volume":"58","author":"Salmanton-Garc\u00eda","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jmii.2024.03.001_bib13","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/jac\/dkad105","article-title":"Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals","volume":"78","author":"Aiello","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2024.03.001_bib14","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s00277-022-04924-6","article-title":"Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies","volume":"101","author":"Magyari","year":"2022","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jmii.2024.03.001_bib15","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jmii.2024.03.001_bib16","series-title":"Clinical spectrum of SARS-CoV-2 infection","year":"2023"},{"key":"10.1016\/j.jmii.2024.03.001_bib17","series-title":"Clinical guideline for patients with COVID-19 [tranditional Chinese version]","year":"2023"},{"key":"10.1016\/j.jmii.2024.03.001_bib18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal","volume":"39","author":"Siddiqi","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jmii.2024.03.001_bib19","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1002\/cncr.33657","article-title":"COVID-19 outcomes in hospitalized patients with active cancer: experiences from a major New York City health care system","volume":"127","author":"Fu","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.jmii.2024.03.001_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","article-title":"Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study","volume":"27","author":"Garcia-Vidal","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jmii.2024.03.001_bib21","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnely","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2024.03.001_bib22","doi-asserted-by":"crossref","first-page":"e810","DOI":"10.1016\/j.clml.2021.07.004","article-title":"Resolution of one-year persisting COVID-19 pneumonia and development of immune thrombocytopenia in a follicular lymphoma patient with preceding rituximab maintenance therapy: a follow-up report and literature review of cases with prolonged infections","volume":"21","author":"Yasuda","year":"2021","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.jmii.2024.03.001_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/ejh.13967","article-title":"Trajectories of the SARS-CoV-2 RNA load in patients with hematological malignancy","volume":"111","author":"Mitsuyuki","year":"2023","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jmii.2024.03.001_bib24","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1056\/NEJMc2031670","article-title":"Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer","volume":"383","author":"Aydillo","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2024.03.001_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/hon.3084","article-title":"Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: a systematic review and meta-analysis","volume":"41","author":"Carrara","year":"2023","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jmii.2024.03.001_bib26","series-title":"Press release [tranditional Chinese version]","year":"2022"},{"key":"10.1016\/j.jmii.2024.03.001_bib27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jinf.2009.12.012","article-title":"Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan","volume":"60","author":"Chien","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.jmii.2024.03.001_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/23744235.2019.1598572","article-title":"Severe lymphopenia in hospitalized patients with influenza virus infection as a marker of a poor outcome","volume":"51","author":"Lalueza","year":"2019","journal-title":"Inf Disp"},{"key":"10.1016\/j.jmii.2024.03.001_bib29","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jmii.2024.03.001_bib30","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/ejh.13916","article-title":"Impaired adaptive immune response in COVID-19 convalescent patients with hematological malignancies","volume":"110","author":"Kalicinska","year":"2023","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jmii.2024.03.001_bib31","article-title":"Distinct systemic immune networks define severe vs. mild COVID-19 in hematologic and solid cancer patients","volume":"13","author":"Pignataro-Oshiro","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jmii.2024.03.001_bib32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.clml.2023.01.006","article-title":"Retrospective review of outcomes of multiple myeloma (MM) patients with COVID-19 infection (Two-Center study)","volume":"23","author":"Ehsan","year":"2023","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.jmii.2024.03.001_bib33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/cancers13030471","article-title":"Lymphopenia as a biological predictor of outcomes in COVID-19 patients: a nationwide cohort study","volume":"13","author":"Lee","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jmii.2024.03.001_bib34","series-title":"COVID-19 vaccines for moderately to severely immunocompromised people","year":"2023"},{"key":"10.1016\/j.jmii.2024.03.001_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.951215","article-title":"Efficacy and safety profile of COVID-19 mRNA vaccine in patients with hematological malignancies: systematic review and meta-analysis","volume":"12","author":"Rinaldi","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jmii.2024.03.001_bib36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41408-022-00778-3","article-title":"One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients","volume":"13","author":"Pinana","year":"2023","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jmii.2024.03.001_bib37","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1182\/bloodadvances.2021006333","article-title":"Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysis","volume":"6","author":"Teh","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jmii.2024.03.001_bib38","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.vaccine.2022.01.040","article-title":"B-cell cytopenia and time to last B-cell-depleting therapy predict response to SARS-COV-2 vaccines in patients with lymphoproliferative disorders","volume":"40","author":"Tanguay","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.jmii.2024.03.001_bib39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.47102\/annals-acadmedsg.2022302","article-title":"Clinical efficacy and long-term immunogenicity of an early triple dose regimen of SARS-CoV-2 mRNA vaccination in cancer patients","volume":"52","author":"Lee","year":"2023","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.jmii.2024.03.001_bib40","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/bjh.18549","article-title":"Antibody status following booster vaccination against SARS-CoV-2 virus in patients with haematologic malignancies","volume":"200","author":"Ikeda","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmii.2024.03.001_bib41","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.3390\/cancers14225512","article-title":"Efficacy of COVID-19 booster vaccines in patients with hematologic malignancies: experiences in a real-world scenario","volume":"14","author":"Krekeler","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jmii.2024.03.001_bib42","doi-asserted-by":"crossref","first-page":"e789","DOI":"10.1097\/HS9.0000000000000789","article-title":"Improved clinical outcome of COVID-19 in hematologic malignancy patients receiving a fourth dose of anti-SARS-CoV-2 vaccine: an EPICOVIDEHA report","volume":"6","author":"Salmanton-Garc\u00eda","year":"2022","journal-title":"Hemasphere"},{"key":"10.1016\/j.jmii.2024.03.001_bib43","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1056\/NEJMc2031670","article-title":"Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer","volume":"383","author":"Aydillo","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2024.03.001_bib44","doi-asserted-by":"crossref","first-page":"e810","DOI":"10.1016\/j.clml.2021.07.004","article-title":"Resolution of one-year persisting COVID-19 pneumonia and development of immune thrombocytopenia in a follicular lymphoma patient with preceding rituximab maintenance therapy: a follow-up report and literature review of cases with prolonged infections","volume":"21","author":"Yasuda","year":"2021","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.jmii.2024.03.001_bib45","article-title":"Antibody level predicts the clinical course of breakthrough infection of COVID-19 caused by delta and omicron variants: a prospective cross-sectional study","volume":"9","author":"Kim","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jmii.2024.03.001_bib46","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jfma.2023.02.008","article-title":"Factors associated with viral rebound among COVID-19 patients receiving oral antivirals","volume":"122","author":"Chen","year":"2023","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2024.03.001_bib47","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1473-3099(22)00873-8","article-title":"Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study","volume":"23","author":"Wong","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2024.03.001_bib48","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000028470","article-title":"Prolonged viral positivity induced recurrent coronavirus disease 2019 (COVID-19) pneumonia in patients receiving anti-CD20 monoclonal antibody treatment: case reports","volume":"100","author":"Deveci","year":"2021","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jmii.2024.03.001_bib49","doi-asserted-by":"crossref","first-page":"608","DOI":"10.7883\/yoken.JJID.2022.092","article-title":"Casirivimab\/imdevimab for active COVID-19 pneumonia which persisted for nine months in a patient with follicular lymphoma during anti-CD20 therapy","volume":"75","author":"Nagai","year":"2022","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.jmii.2024.03.001_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.992137","article-title":"B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: a European Hematology Association Survey (EPICOVIDEHA)","volume":"12","author":"Infante","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jmii.2024.03.001_bib51","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hon.3048","article-title":"Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: a report from the ITA-HEMA-COV","volume":"40","author":"Zappasodi","year":"2022","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jmii.2024.03.001_bib52","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study","volume":"10","author":"Gangneux","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jmii.2024.03.001_bib53","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13054-021-03753-9","article-title":"Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study","volume":"25","author":"Hatzl","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.jmii.2024.03.001_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2021.115347","article-title":"Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection","volume":"100","author":"Cogliati Dezza","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2024.03.001_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1087800","article-title":"Factors associated with prolonged viral shedding in older patients infected with Omicron BA.2.2","volume":"10","author":"Zhong","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.jmii.2024.03.001_bib56","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.4187\/respcare.10567","article-title":"Factors associated with prolonged ventilation in patients receiving prone positioning protocol with muscle relaxants for severe COVID-19 pneumonia","volume":"68","author":"Hoshino","year":"2023","journal-title":"Respir Care"},{"key":"10.1016\/j.jmii.2024.03.001_bib57","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2666-5247(20)30172-5","article-title":"SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis","volume":"2","author":"Cevik","year":"2021","journal-title":"Lancet Microbe"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118224000471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118224000471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T11:49:03Z","timestamp":1717501743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118224000471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1684118224000471"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2024.03.001","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2024.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}